Answers are grounded in this paper and cite their sources.
The emergence of multidrug-resistant (MDR) pathogens within biofilms in the cystic fibrosis lung results in increased morbidity. An inhalation therapy derived from alginate, OligoG CF-5/20, is currently in clinical trials for cystic fibrosis patients.
No takes yet. Share an insight, caveat, or question.
Oakley et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: